Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ ChemMedChemarrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
ChemMedChem
Article
Data sources: UnpayWall
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao
ChemMedChem
Article . 2010 . Peer-reviewed
License: Wiley Online Library User Agreement
Data sources: Crossref
ChemMedChem
Other literature type . 2010
versions View all 3 versions
addClaim

“Hot Spots” in Medicinal Chemistry

Authors: Metternich R.; TARZIA, GIORGIO;

“Hot Spots” in Medicinal Chemistry

Abstract

What are the Current Challenges in Medicinal Chemistry? A small minority of the diseases that accompany our lives can be cured, many more are treated to a satisfactory extent, and others are currently in need of acceptable treatments. It is on this last group that we focus our discussion. The classical criteria of distinguishing between developing and developed countries, transmittable and non-transmittable diseases, incidence and prevalence, fundamental knowledge about the etiology of the disease sufficient to develop a useful drug and the need of a market that may repay the expenses are instrumental to the coming considerations. The underdeveloped and developing countries have health emergencies of their own, mostly due to transmittable diseases, some of which are typical for the given country’s climate. A negative interplay between poor knowledge of the etiology of these diseases and poor economic conditions of the affected populations leads to the poorest medical results. Between 1975 and 2004 only 20 drugs were registered for the treatment of tuberculosis, malaria, and tropical diseases, compared with 1556 drugs for treating diseases in the developed world. The situation is now changing for a number of reasons that are beginning to bridge economy with ethics, and neglected and tropical diseases are now under greater focus, although the situation will remain critical until the problem of patents and intellectual property (IP) protection at large, is solved. The Massachusetts Institute of Technology (MIT) has taken a positive step forward in this area by reaching an agreement with South Africa, 08/2010 ChemMedChem, European in origin but international in scope, deals with all aspects of drug discovery. It is co-owned by Chemistry Publishing Society Europe (ChemPubSoc Europe) and is published by Wiley-VCH. Contributions in ChemMedChem cover medicinal and pharmaceutical sciences, drug design, drug development and delivery, molecular modeling, combinatorial chemistry, target validation, lead generation, and ADMET studies, that is, research from the overlapping areas between biology, chemistry, and medicine. ChemMedChem publishes Communications and Full Papers, as well as Reviews, Minireviews, Highlights, Concepts, Essays, Book Reviews, and occasionally Conference Reports. Authors can submit manuscripts to ChemMedChem online through our homepage (see over) by clicking on “Online Submission” and following the simple instructions.

Country
Italy
Related Organizations
Keywords

Aging, Diabetes Mellitus, Type 2, Alzheimer Disease, Chemistry, Pharmaceutical, Neurodegenerative Diseases, Communicable Diseases

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    4
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
4
Average
Average
Average
bronze